Renal news roundup from AKF

The Kidney Disease: Improving Global Outcomes organization has released updated guidelines for managing chronic kidney disease (CKD), featuring new recommendati...

The Food and Drug Administration (FDA) has approved Novartis' Fabhalta, or iptacopan, as the first treatment for C3 glomerulopathy (C3G), a rare kidney dis...

Research published in BMC Nephrology supported the use of urine test strips as a screening tool for CKD in low-risk patients. The albumin-to-creatinine ratio wa...

The FDA has approved Scienture's losartan potassium oral suspension, Arbli, to reduce stroke risk in patients with hypertension and left ventricular hypert...

The FDA says a shortage of hemodialysis bloodlines, which connect patients to dialysis machines, could last into early fall due to supply issues. The agency is ...

The global burden of diabetic nephropathy has increased from 1990 to 2021 and is projected to continue rising through 2050, according to a study in Frontiers in...

The addition of metformin to SGLT2 inhibitors was associated with reductions in kidney disease progression and mortality in patients with type 2 diabetes, accor...

A retrospective study in Frontiers in Endocrinology found that managing dyslipidemia may help protect kidney function in patients with diabetes. High triglyceri...

The Centers for Medicare and Medicaid Services (CMS) Innovation Center is ending the End Stage Renal Disease Treatment Choices, Primary Care First and Making Ca...